Todas para una, uno para todaspoliautoinmunidad a propósito de un caso

  1. Manuel Flores Sáenz 1
  2. Ana Pérez Gómez 1
  1. 1 Universidad de Alcalá (Alcalá de Henares)
Revista:
RIECS: Revista de Investigación y Educación en Ciencias de la Salud

ISSN: 2530-2787

Año de publicación: 2023

Volumen: 8

Número: 1

Páginas: 130-133

Tipo: Artículo

DIALNET GOOGLE SCHOLAR

Otras publicaciones en: RIECS: Revista de Investigación y Educación en Ciencias de la Salud

Resumen

A case of a 50-year-old woman who came to the Rheumatology Department of theHospital Universitario Príncipe de Asturias from Primary Care due to triphasic Rynaud's Syndrome of 1 year of evolution. In the anamnesis for connective tissue disease, xerophthalmia, xerostomia and dysphagia for solids of months of evolution were highlighted. After performing the relevant complementary tests, she met the criteria for diagnosis of Dermatomyositis, Sjögren's syndrome, Fibromyalgia and CREST syndrome (calcinosis, Rynaud, esophageal dysfunction and Sclerodactyly). During the monthly follow-up, the patient consulted for generalized musculoskeletal pain that revealed positivization of anti-citrullinated peptide antibodies.

Referencias bibliográficas

  • Singal AP, J. Porphyria Cutanea Tarda. Ferreira G, editor. Hackensack, NJ, USA: World Scientific Publishing Co. Pte. Ltd.?; 2014.
  • Singal AK. Porphyria cutanea tarda: Recent update. Mol Genet Metab. noviembre de 2019;128(3):271-81.
  • Quansah R, Cooper CJ, Said S, Bizet J, Paez D, Hernandez GT. Hepatitis C- and HIV-induced porphyria cutanea tarda. Am J Case Rep. 2014;15:35-40.
  • Vieira FMJ, Aoki V, Oliveira ZNP de, Martins JEC. Study of direct immunofluorescence, immunofluorescence mapping and light microscopy in porphyria cutanea tarda. An Bras Dermatol. 2010;85(6):827-37.
  • Shieh S, Cohen JL, Lim HW. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol. abril de 2000;42(4):645-52.
  • Aguilera P, Laguno M, To-Figueras J. Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital. Photodermatol Photoimmunol Photomed. marzo de 2016;32(2):93-7.
  • Stölzel U, Kubisch I, Stauch T. [Porphyrias-what is verified?]. Internist. diciembre de 2018;59(12):1239-48.
  • Stölzel U, Doss MO, Schuppan D. Clinical Guide and Update on Porphyrias. Gastroenterology. agosto de 2019;157(2):365-381.e4.
Fuente de los datos: Dialnet